Skip to content
Διάρκεια άρθρου: Λιγότερο απο 1 λεπτό Λεπτά

Νέα θεραπευτική επιλογή για το πολλαπλό μυέλωμα, με ελληνική «σφραγίδα» – Πράσινο φως από τον FDA για την ιμπερδομίδη




Νέα θεραπευτική επιλογή για το πολλαπλό μυέλωμα, με ελληνική «σφραγίδα» – Πράσινο φως από τον FDA για την ιμπερδομίδη – Newsbeast<meta name="description" content="Μια σημαντική εξέλιξη στη θεραπεία του πολλαπλού μυελώματος αποτελεί η πρόσφατη επιταχυνόμενη έγκριση από τον Οργανισμό Τροφίμων και Φαρμάκων των ΗΠΑ (FDA) της ιμπερδομίδης (iberdomide), ενός νέου, από του στόματος παράγοντα της κατηγορίας CELMoD (Cereblon E3 Ligase Modulator), σε συνδυασμό με δαρατουμουμάμπη και δεξαμεθαζόνη."><meta name="robots" content="index, follow"><meta property="og:title" content="Νέα θεραπευτική επιλογή για το πολλαπλό μυέλωμα, με ελληνική «σφραγίδα» – Πράσινο φως από τον FDA για την ιμπερδομίδη"><meta property="og:type" content="article"><meta property="og:image" content="https://www.newsbeast.gr/image/s1200x762/fill/file/files/1/2025/09/ERGASTHRIO1.jpg"><meta property="og:url" content="https://www.newsbeast.gr/health/arthro/13362304/nea-therapeftiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-iberdomidi"><meta property="og:description" content="Η έγκριση αφορά ενήλικες ασθενείς με πολλαπλούν μυέλωμα που έχουν λάβει τουλάχιστον μία προηγούμενη γραμμή θεραπείας"><meta property="og:locale" content="el_GR"><meta property="og:site_name" content="Newsbeast"><meta property="og:image:url" content="https://www.newsbeast.gr/image/s1200x762/fill/file/files/1/2025/09/ERGASTHRIO1.jpg"><meta property="og:image:width" content="1200"><meta property="og:image:height" content="762"><meta property="article:published_time" content="2026-09-17T08:26:00.000Z"><meta property="article:section" content="ΥΓΕΙΑ"><meta property="article:tag" content="FDA"><meta property="article:tag" content="ασθένεια"><meta property="article:tag" content="ασθένειες"><meta property="article:tag" content="ασθενείς"><meta property="article:tag" content="ΕΚΠΑ"><meta property="article:tag" content="θεραπεία"><meta property="article:tag" content="θεραπείες"><meta property="article:tag" content="πολλαπλούν μυέλωμα"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content="@newsbeast"><meta name="twitter:title" content="Νέα θεραπευτική επιλογή για το πολλαπλό μυέλωμα, με ελληνική «σφραγίδα» – Πράσινο φως από τον FDA για την ιμπερδομίδη"><meta name="twitter:image" content="https://www.newsbeast.gr/image/s1200x762/fill/file/files/1/2025/09/ERGASTHRIO1.jpg"><meta name="twitter:description" content="Μια σημαντική εξέλιξη στη θεραπεία του πολλαπλού μυελώματος αποτελεί η πρόσφατη επιταχυνόμενη έγκριση από τον Οργανισμό Τροφίμων και Φαρμάκων των ΗΠΑ (FDA) της ιμπερδομίδης (iberdomide), ενός νέου, από του στόματος παράγοντα της κατηγορίας CELMoD (Cereblon E3 Ligase Modulator), σε συνδυασμό με δαρατουμουμάμπη και δεξαμεθαζόνη."><meta name="twitter:creator" content="@newsbeast"><br> <main class="container defViewPadder"> <article class="_articleDefault_1hp20_1"> <category-and-tags class="_categoryAndTagsCnt_18ubh_63 _singleLine_18ubh_74"> </category-and-tags> <h2 class="_articleSubTitle_18ubh_35">Η έγκριση αφορά ενήλικες ασθενείς με πολλαπλούν μυέλωμα που έχουν λάβει τουλάχιστον μία προηγούμενη γραμμή θεραπείας</h2> </article> <p> </p></main> <div class="container" data-astro-cid-a3jj45ac=""> <section class="_marketNews" data-astro-cid-tvkb6kqx=""> <h2 data-astro-cid-tvkb6kqx="">MARKET NEWS</h2> </section></div> <articles-inf-feed class="noPrint" postid="13362304"> </articles-inf-feed> <div class="article-point"> Το πρωτότυπο άρθρο <a target="_blank" href="https://www.newsbeast.gr/health/arthro/13362304/nea-therapeftiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-iberdomidi" style="white-space: nowrap;width: 300px;overflow: hidden">https://www.newsbeast.gr/health/arthro/13362304/nea-therapeftiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-iberdomidi</a> ανήκει στο <a target="_blank" href="https://www.newsbeast.gr/health/arthro/13362304/nea-therapeftiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-iberdomidi">ΥΓΕΙΑ – Newsbeast</a> . </div> <div class="xs_social_share_widget xs_share_url after_content main_content wslu-style-2 wslu-share-box-shaped wslu-fill-colored wslu-share-m-5 wslu-none wslu-share-horizontal wslu-theme-font-yes wslu-main_content"> <ul> <li class="xs-share-li facebook-messenger wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_facebook-messenger" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="facebook-messenger" data-xs-href="https://www.facebook.com/dialog/send?link=https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&redirect_uri=https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&display=popup&app_id=2577123062406162"> <div class="xs-social-icon"> <span class="met-social met-social-facebook-messenger"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Facebook-messenger </div> </div> </a> </li> <li class="xs-share-li viber wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_viber" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="viber" data-xs-href="viber://forward?text=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7+https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F"> <div class="xs-social-icon"> <span class="met-social met-social-viber"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Viber </div> </div> </a> </li> <li class="xs-share-li whatsapp wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_whatsapp" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="whatsapp" data-xs-href="whatsapp://send?text=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7+https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F"> <div class="xs-social-icon"> <span class="met-social met-social-whatsapp"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Whatsapp </div> </div> </a> </li> <li class="xs-share-li facebook wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_facebook" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="facebook" data-xs-href="http://www.facebook.com/sharer.php?u=https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&t=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7&v=3"> <div class="xs-social-icon"> <span class="met-social met-social-facebook"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Facebook </div> </div> </a> </li> <li class="xs-share-li twitter wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_twitter" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="twitter" data-xs-href="https://twitter.com/intent/tweet?text=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7+https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&original_referer=https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&related=xpeedstudio"> <div class="xs-social-icon"> <span class="met-social met-social-twitter"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Twitter </div> </div> </a> </li> <li class="xs-share-li telegram wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_telegram" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="telegram" data-xs-href="https://telegram.me/share/url?url=https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&text=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7"> <div class="xs-social-icon"> <span class="met-social met-social-telegram"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Telegram </div> </div> </a> </li> <li class="xs-share-li email wslu-no-extra-data"> <a href="#" class="xs-share-link" id="xs_feed_email" data-pid="26114" data-uri_hash="af15cf690564ab259e426db32d95937b" data-key="email" data-xs-href="mailto:?body=Title%3A+%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7+%5Cn%5Cn+URL%3A+https%3A%2F%2Fzoumekalytera.gr%2Fygeia%2Fnea-therapeytiki-epilogi-gia-to-pollaplo-myeloma-me-elliniki-sfragida-prasino-fos-apo-ton-fda-gia-tin-imperdomidi%2F&subject=%CE%9D%CE%AD%CE%B1+%CE%B8%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CF%85%CF%84%CE%B9%CE%BA%CE%AE+%CE%B5%CF%80%CE%B9%CE%BB%CE%BF%CE%B3%CE%AE+%CE%B3%CE%B9%CE%B1+%CF%84%CE%BF+%CF%80%CE%BF%CE%BB%CE%BB%CE%B1%CF%80%CE%BB%CF%8C+%CE%BC%CF%85%CE%AD%CE%BB%CF%89%CE%BC%CE%B1%2C+%CE%BC%CE%B5+%CE%B5%CE%BB%CE%BB%CE%B7%CE%BD%CE%B9%CE%BA%CE%AE+%C2%AB%CF%83%CF%86%CF%81%CE%B1%CE%B3%CE%AF%CE%B4%CE%B1%C2%BB+%E2%80%93+%CE%A0%CF%81%CE%AC%CF%83%CE%B9%CE%BD%CE%BF+%CF%86%CF%89%CF%82+%CE%B1%CF%80%CF%8C+%CF%84%CE%BF%CE%BD+FDA+%CE%B3%CE%B9%CE%B1+%CF%84%CE%B7%CE%BD+%CE%B9%CE%BC%CF%80%CE%B5%CF%81%CE%B4%CE%BF%CE%BC%CE%AF%CE%B4%CE%B7"> <div class="xs-social-icon"> <span class="met-social met-social-email"></span> </div> <div class="wslu-hover-content"> <div class="xs-social-followers"> 0 </div> <div class="xs-social-follower-text"> </div> <div class="xs-social-follower-label"> Email </div> </div> </a> </li> </ul> </div>
‹ ›